Introduction
Prolidase deficiency (PD) is an autosomal recessive disorder characterized by absent or reduced enzymatic activity of the metallodipeptidase prolidase. PD is a rare disease with an estimated occurrence of one case in one to two million births [1] and is thus classified as an orphan disease (http://www.orphanet.net; http:// www.orpha.net/consor/cgi-bin/index.php).
Approximately 90 individual cases have so far been documented in the literature [2] . Affected individuals can develop clinical syndromes over a wide range from mild to very severe [3, 4] . Disease symptoms include ulcerations and other dermatologic manifestations, telangiectasis, impetigo-like eruptions, lesions, and necrotic papules (http://omim.org; http://omim.org/ Abbreviations 2-ME, b-mercaptoethanol; DPI, diffraction data precision index; DTT, dithiothreitol; HsProl, human prolidase; Hyp, hydroxyproline; NCS, noncrystallographic symmetry; PD, prolidase deficiency; Pro, proline; Rms, root mean square; TEV, Tobacco Etch Virus protease; TLS, translation/libration/screw; wt, wild-type. entry/170100). Mental retardation, respiratory tract infections and facial dysmorphisms are also sometimes observed. Mostly, the clinical symptoms are detected after birth or in very early childhood [5] . To date no definitive cure against PD is available, although different therapies are being tried. These include topical Gly and Pro administration, oral administration of Mn 2+ and ascorbic acid, corticosteroids, or blood transfusions. Enzyme replacement therapy has also been investigated as an option [3, 6] and recently, Besio and colleagues reported that about 22% of prolidase activity could be restored for the Gly448Arg variant of HsProl when chaperone expression was induced [7] .
PD is a disease, which is caused by a variety of aberrations, all of them located in the prolidase-coding PEPD gene. To date, a total of 29 mutations in the PEPD gene have been reported, all of which result in partial or complete enzyme inactivation. Six known mutations result in single amino acid substitutions and two further ones in single amino acid deletions in the prolidase gene product. These eight mutations (Fig. 1A , Table 1 ) are the subject of this report. Other mutations introduce premature stop codons into the PEPD gene or result in partial PEPD gene deletions, which then lead to the expression of incomplete prolidase constructs. The most recent discovery in the latter respect is a deletion of approximately 196 kb in the PEPD gene [8] .
The enzyme prolidase is found in archaea, bacteria, and eukaryotes. Prolidase is a metal-dependent dipeptidase with a high specificity for peptides containing Pro or hydroxyproline (Hyp) on their C-termini. Prolidase from Homo sapiens (HsProl) is a homodimeric, cytosolic enzyme consisting of two 493 amino acid long polypeptide chains [9] . Each subunit can be divided into two domains: the N-terminal domain (residues 1-184) and the C-terminal domain (residues 185-493). The C-terminal domain shares the pita-bread fold with other peptidases such as aminopeptidase P, methionine aminopeptidase, and creatinase [10] and harbors the active site of the enzyme. The pita-bread fold is characterized by highly bent b-sheets flanked by a-helices. Usually, a bimetallic center is located at the bottom of a deep cleft formed by the secondary structure elements. This metal-binding center constitutes the base of the active site of the enzyme (Fig. 1B) . For full activity HsProl requires the presence of two Mn 2+ -ions in the active site [11, 12] . As in all enzymes belonging to the pita-bread family one of the ions is tightly bound, whereas the other one is bound less tightly. As described previously [9] , in the structure of wild-type (wt) HsProl, the prolidase substrate GlyPro is coordinated mostly through its C-terminal part, while its Nterminal amino acid part interacts with the enzyme only loosely mainly through hydrophobic interactions. In particular, the side chain of His255 undergoes a shift of as much as 6 A upon substrate binding. Also, the ahelix-containing surface loop 100-112 from the other subunit is moved in toward the active site resulting in Fig. 1 . Overall structure of wt-HsProl. (A) Overall structure of the wt-HsProl dimer in complex with its preferred substrate GlyPro (PDB-Id 5M4J [9] ). The protein is depicted as ribbons (one subunit in yellow and the other one in white) and GlyPro as black spheres. The red stars highlight the location of the mutation sites discussed in this report. (B) Architecture of the active site of wt-HsProl. The important active site constituents are labeled. The substrate GlyPro is shown in ball-and-stick representation with standard atom coloring. In case of the ternary wtHsProl structure, sodium ions (here shown as marine spheres) were present instead of the manganese ions. The (2F o À F c )-composite omit electron density map contoured at 2.2 r is shown for the substrate GlyPro and the Na + ions as a blue mesh. (B) Reference figure for all following active site figures of the eight prolidase variants discussed in this work. All active site figures are shown in the same orientation.
Trp107 being able to act as a seal of the active site. In Wilk et al. [9] , we were also able to demonstrate that the Mn-bridging water molecule is most likely activated to a more nucleophilic hydroxide ion, which facilitates peptide hydrolysis. For some time, researchers have tried to explain the influence of particular mutations on the protein structure and function and their relation to disease. Due to the lack of experimental evidence for the structural differences induced by single amino acid alterations, molecular modeling was employed as the method of choice to investigate this problem [7] . Here, we present for the first time direct evidence for the structural changes induced by the relevant point mutations. High resolution (1.43-1.91 A) and high-quality crystal structures (Tables 2 and 3) of the eight selected disease-causing mutants of HsProl in complex with Mn 2+ ions and the most preferred substrate GlyPro reveal four distinct mechanisms of prolidase inactivation. These will be described in the following.
Results
The structure of the Arg184Gln variant (PDB Id 5MBY), which shows residual activity in the crystal
In the wt-HsProl structure Arg184 is positioned approximately 14 A from the active site as defined by the shortest atom-to-atom distance between Arg184 and the substrate GlyPro. The guanidinium moiety of Arg184 is engaged in two direct interactions with the acidic amino acids Asp375 and Asp378. These interactions are lost when the positively charged guanidinum group of Arg184 is replaced by the neutral amide group of Gln (Fig. 2) . The electron density maps in the mutant structure (PDB-Id 5MBY) clearly indicate the presence of the shorter Gln side chain and reveal that an additional water molecule is positioned close to where the guanidinum group of Arg184 was in the wt enzyme ( Fig. 2A) . In the absence of any ligands in the soaking and cryo-solution, the position of the bridging hydroxide ion was taken up by a cacodylate ion from the buffer (PDB-Id 6H2P). This cacodylate was also observed in the structure of prolidase from Lactococcus lactis [13] . It assumes a position similar to the phosphate ion position, which was observed in the very first deposited human prolidase structure (PDB-Id 2OKN, U. Mueller, F. H. Niesen, Y. Roske, F. Goetz, J. Behlke, K. Buessow, U. Heinemann, Protein Structure Factory, unpublished data).
The presence of both Mn 2+ ions in positions matching the ones observed in the wt-HsProl structure [PDB-Id 5M4G, 9] can be ascertained by analyzing the corresponding anomalous difference electron density map. Mn499 and Mn500 appear at r-levels of roughly 55 and 70, respectively. No significant structural differences were observed outside the active site compared to the wt enzyme. After soaking a crystal with the substrate GlyPro, the bridging hydroxide ion could be observed and the substrate appeared to be cleaved. A large negative difference electron density peak was observed around the substrate's peptide bond and positive difference peaks were present at both termini of the dipeptide. This is indicative of a shift of both product amino acids into opposite directions. In No. of crystals the refined model the proline ring was shifted by 0.6 A from its position in the wt-HsProl-Na-GlyPro complex, and the carboxyl group of Pro was shifted by 0.3 A. Despite the shift, the Pro moiety maintains the two H-bonds with Arg398. His255, which is also coordinating the Pro carboxyl group was shifted by 0. 7 A so that the hydrogen bond with the Pro carboxylate is also retained, but at the same time a new interaction with the Pro imine group is formed. Gly, the second product of hydrolysis, was characterized by somewhat weaker electron density. In one of the prolidase subunits the electron density could only be explained when it was modeled in two conformations. In both conformations the amine end is anchored to Mn500 and the carboxylic group swung away from the metal ions toward the exit of the active site, where both of its oxygen atoms are coordinated by His377. In the wt-HsProl structure His377 binds the carbonyl oxygen of the peptide. When a crystal was soaked with the less favored substrate LeuPro, the electron density revealed a similar position and orientation of the Pro product, and a somewhat differently oriented Leu compared to Gly. Its carbonyl C-atom appeared to be shifted toward the Mn 2+ ions and formed a covalent adduct with the bridging hydroxide ion (PDB-Id 6H2P). Attempts to further lower the residual in crystallo activity of the enzyme by lowering pH of the soaking solution to 6.3 led to the presence of rather diffuse and hard-tointerpret electron density around the ligands (both GlyPro and LeuPro were tested). Most likely, this was a result of the coexistence of both intact and cleaved ligands. It turned out to be impossible, however, to reliably model such a situation based on the available data.
The structure of the Ser202Phe variant (PDB-Id 5MBZ) displays structural disorder
The amino acid Ser202 is localized in the helical region approximately 12 A away from the active site (the distance from the atom Ser202-OG is 11.9 to the nearest of the two Mn 2+ , and 11.4 A to the substrate's N-terminus). The site of the mutation Ser202Phe can be clearly observed in the electron density map (Fig. 3A) . In the wt-HsProl structure, the atom Ser202-OG engages in a hydrogen bond to the amide nitrogen of Gly279, which is localized on the b-sheet region adjacent to the metal-binding site (this region also contains the Mn-binding Asp276). The substitution of Ser by the much bulkier Phe results in the loss of this interaction and the mechanic repulsion of the b-strand 277-280. This chain segment moves out of the way, which in turn introduces disorder deeper in the protein core (Fig. 3B) . As a result, the Ser202Phe substitution causes disorder in the chain fragments 239-244 and 257-258 to an extent, that they could not be traced anymore in the electron density. Furthermore, the chain fragment 259-264 assumes a structure completely different from the one observed in the wt-HsProl structure. In the active site, the position and orientation of all the metal-binding amino acid side chains is the same as observed in the wt-HsProl structure and both Mn 2+ ions are present as evidenced by the anomalous difference electron density map (Fig. 3C , Table 4 ). The substrate GlyPro is clearly present as well, exhibiting well-defined electron density as is the catalytic OH À ion situated about 1.8 A away from Mn500. This leaves the active site in a catalytically competent state; however, hydrolysis does not occur. The only notable difference in the active site vicinity is the absence of Tyr241, which is one of the residues which became disordered. In the wt-HsProl structure Tyr241 interacts with the metal-binding aspartates and is closing the active site on the side where the substrate's N-terminus is placed.
The structure of the DTyr231 variant (PDB-Id 5MB0) features an affected dimer interface
The amino acid Tyr231 is located approximately 24 A from the active site Mn 2+ ions near the end of the antiparallely arranged dimer interface a-helices consisting of the chain stretch Glu219-Gly234 of the two subunits A and B (Fig. 4A) . The hydroxyl group of Tyr231 is involved in a hydrogen bond with the side chain of Glu223 of the opposing subunit. When the Tyr is deleted its position is taken over by the neighboring Ser231 residue (please note that Ser232 in the wt-HsProl structure is now Ser231 due to the loss of one amino acid in the sequence). As a consequence, the a-helix is shortened from its C-terminal side as judged from the electron density maps. The direct Tyr231(A)-Glu223(B) H-bond is replaced by a water-mediated hydrogen bond connecting the carboxylic oxygen atoms of Glu223 and the main chain carbonyl oxygen atom of Ser231. In addition, Ser231-OG is now involved in a direct hydrogen bond with Ser224, which is localized near the Nterminal end of the corresponding a-helix from subunit B (Fig. 4B) . These structural changes alter the total interface and the corresponding free energy of association. However, the changes in the interface area (177 A   2 ) and corresponding free energy of association
) as calculated by the PDBEPISA [14] server seem negligible. The composition of the active site appears to be unaltered compared to the wt enzyme. Clear electron density can be observed for the bound substrate, the two Mn 2+ ions and the bridging hydroxide ion. Furthermore, the anomalous difference electron density map exhibits clear peaks at both Mn positions (Fig. 4C, Table 4 ).
The structure of the Asp276Asn variant (PDB Id 5MC1) shows the loss of one of the catalytic metal ions
The amino acid Asp276 is localized right in the active site of prolidase (Fig. 5A ) and takes part in the coordination of one of the Mn 2+ ions (Mn500). The exchange of an oxygen atom from the carboxylic group of Asp to a nitrogen atom results in the loss of negative charge. As a result, the formal charge is changed from À1 to 0. This affects the electrostatic environment of the active site and obviously the binding of the metal ions. As is evidenced by the anomalous difference electron density map (Fig. 5C, Table 4 ) only the Mn 2+ ion Mn499 is present adjacent to His370. No anomalous signal is observed at the position of the Mn 2+ ion Mn500, which is the Mn 2+ ion adjacent to Asp276 in wt-HsProl. Consequently, the entity next to Asn276 was modeled as a Na + ion. No electron density for the bridging hydroxide could be observed, which led us to the conclusion that it was not present in this variant. No other significant differences compared to wt-HsProl could be discerned.
The structure of the Gly278Asp variant (PDB Id 5MC2) displays some chain disorder and shows the loss of one of the catalytic metal ions
The amino acid Gly278 is localized on the one of the pita-bread b-strands in close proximity to the ion- binding aspartates Asp276 and Asp287. The substitution of this Gly by an Asp results in a shift of the sequence stretch 276-280 by up to 2.2 A (Fig. 6A ). More pronounced changes can be observed at the position of Tyr241. The newly introduced side chain of Asp278 locates to exactly the same place where Tyr241 is found in wt-HsProl. Consequently, the Asp278 side chain pushes against Tyr241 and leads to a displacement of Tyr241. Compared to the wtHsProl structure the atom Tyr241-OH moves by 11.8 A and the atom Tyr241-CA by 4.6 A. This shift completely alters the trace of the sequence fragment 235-244, whose new orientation further disturbs the 257-261 part of the same chain (Fig. 6B) . Interestingly, the observed changes are clearly different in the two subunits. The structure in chain A resembles the wt protein structure, while in chain B a large fragment (residues 248-261) assumes a slightly different structure. A total of nine amino acid residues could not be traced in the electron density at all within this region. With respect to active site architecture, the side chains of Asp276 and Asp287 are slightly rotated and/or shifted (Fig. 6C ) compared to the wt structure. In the wt enzyme both of them are in hydrogen bond distance to Tyr241-OH, which presumably stabilizes their positions. In this variant, Tyr241 is pushed away by Asp278 and hence this source of stabilization is lost. Interestingly, the ligand-binding residue His255 in subunit B is found 29 A from the ligand position while in subunit A it remains in the usual position. However, it does exhibit very high ADP values (~90 A 2 ) and is just barely traceable. The inspection of the anomalous difference electron density map revealed that in both subunits one of the Mn 2+ ions (Mn500) was replaced by presumably a sodium ion, while the other Mn 2+ ion (Mn499) was still in place (Fig. 6C, Table 4 ). The binding of the substrate GlyPro seems to be unaffected by the introduced amino acid change.
The structure of the Glu412Lys variant (PDB Id 5MC3) features the substitution of one of the catalytic metal ions by an amino acid side chain
The amino acid Glu412 is located in the active site and coordinates both Mn 2+ ions in the wild-type enzyme structure (Fig. 7A) . Glu412 is also considered as the proton shuttle, which activates the catalytic water molecule to a hydroxide ion and which provides a proton to the amide N of the cleaved peptide bond [9] . In the Glu412Lys mutant the positively charged eamino group of the newly introduced Lys amino acid protrudes into the Mn499-binding site and blocks the position for another cation. In the refined structure the Lys412-NZ atom is located only about 0. 7 A from the Mn499 position in wt-HsProl. The analysis of the anomalous difference electron density map confirms the presence of only one Mn 2+ per active site ( Fig. 7C , Table 4 ). Interestingly, it is the ion which is more tightly bound in the wt-HsProl structure that it lost upon this change. Therefore, it is no surprise that this change renders the enzyme completely inactive. The binding of the substrate GlyPro seems to be unaffected and no significant structural changes can be observed away from the point of mutation. Overall, this structure is highly similar to the wt-HsProl structure with an overall r.m.s. difference between C a -atoms of only 0.27 A.
The structure of the Gly448Arg variant (PDB Id 5MC4) features a dysfunctional protein core
The amino acid Gly448 is located far away from the active site at the beginning of the b-strand 448-457. It is in close proximity to the short a-helical fragment (249-252) of one of the surface loops. The exchange of the hydrogen atom of the Gly for the rather bulky side chain of Arg (Fig. 8A ) results in a severe clash of the newly introduced side chain with this a-helix. Consequently, it was observed, that the b-strand hosting the mutation site remains unchanged, but the loop 247-261 was pushed aside and became disordered to an extent that it could not be traced anymore in the electron density. Moreover, the chain fragment 252-262, which is still visible in subunit B assumes a different structure than in the wild-type enzyme. Ala252 is now located approximately 12 A from its original position (Fig. 8B) . Similar to the case of the Gly278Asp variant, the substrate coordinating residue His255 is now completely absent from the active site and is either disordered or located about 19 A away from its functional position. In the case of wt-HsProl the a-helix 102-108 is moved upon substrate binding to seal the catalytic cleft. In the case of the Gly448Arg variant this region has become significantly more disordered. In subunit B three of the residues of this helix including the bulky Trp107 could not be modeled at all. The soaked-in GlyPro substrate is clearly visible in both subunits and positioned just like in the native enzyme. Also, both Mn 2+ ions are present in their expected positions (Fig. 8C) . Just like in the wt-HsProl structure (PDB Id 5M4G, [9] ), the tightly bound Mn499 displays a stronger anomalous signal in the corresponding anomalous difference density peak than Mn500 (Table 4 ).
The structure of the DGlu452 variant (PDB Id 5MC5) exhibits surprising active site preservation
The amino acid Glu452 is one of the active site residues. It lies at one of the b-strands at the bottom of the Mn-binding cavity and just like Glu412 coordinates both Mn 2+ ions. Unexpectedly, upon deletion of this residue no structural differences could be observed within the active site compared to the wt-HsProl structure (Fig. 9A) . A closer inspection of the electron density revealed, however, that the position of the missing Glu was taken by the following residue (Glu453 in wt-HsProl). This in turn was replaced by the following Asp residue, which still preserves the local charge distribution (Fig. 9B ). This zipper-like hopping of amino acid residues into the position of their respective preceding residues extends until the protein surface is reached at Ser460 (Ser459 in the variant). In effect, only the turn between two antiparallel b-strands is now shortened by one amino acid with no other differences in the main chain being observed. Also the substrate, both Mn 2+ ions and the bridging OH À ion are present in their respective positions (Fig. 9C , Table 4 ).
Discussion
Missense mutations are common genetic variations often associated with hereditary disorders. They can affect the coded gene product in various ways leading to impaired protein function. Affects can be direct, for instance, when functional residues of the gene product are the targets of variation or indirect, for instance through destabilization, improper folding or aggregation of the protein. In many cases biochemical data are available, but a structural basis supporting such data is lacking. This is in particular the case for rare (orphan) diseases such as PD, since such diseases are of limited interest for drug development by the pharmaceutical industry. Here, we present the high-resolution crystal structures of eight single amino acid variants (six point mutations and two deletions), which were identified in patients suffering from PD. The overall structural differences compared to the fully functional wild-type enzyme, as well as ligand binding and catalytic center architecture were scrutinized in detail. In all analyzed mutations, the binding of the substrate seems to be more or less unaffected. However, other effects of the mutations could be identified, which are potentially relevant for the reduced protein function. These will be described in the following.
Disruption of the catalytic Mn 2 (OH À )-center
The hydrolytic cleavage of a peptide bond requires the presence of a catalytic nucleophile. In the case of prolidase it was suggested, that a water molecule is activated to a hydroxide ion by the two Mn 2+ ions and by an acidic residue in the enzyme's catalytic center (PDB Id 5M4G [9] ). Consequently, the most obvious place to look for changes that could affect enzyme activity is this center. Indeed, three of the eight prolidase variants (Table 1) are characterized by the loss of one of the catalytic metal ions. In variants 4 (Asp276Asn, PDB Id 5MC1) and 5 (Gly278Asp, PDB Id 5MC2) Mn500 is lost, whereas in variant 6 (Glu412Lys, PDB Id 5MC3) Mn499 is lost. In case of the Asp276Asn mutation, it is likely the removal of a negative charge that leads to the loss of one of the Mn 2+ ions, whereas in the Gly278Asp case (variant 5) some degree of disorder is introduced owing to clashes with the newly present Asp side chain. As a consequence, some important active site residues (Tyr241 and His255) are displaced from their original positions and the side chain of Asp287 is rotated by about 30°. It is likely that these changes are the cause for the reduced Mn 2+ affinity. In variant 6, the positively charged Mn 2+ ion is replaced by the side chain amino group of Lys412. This change is accompanied by an increased active site flexibility and leads to a complete loss of enzyme activity. It is interesting to note for this variant, that in earlier modeling studies [7] , this effect was not predicted. It is also surprising that biochemical studies on this variant mutant suggested the presence of both ions and hinted at slightly increased affinity [7] . This is clearly in contradiction to the results presented here. Since it may be, however, that once Lys412 assumed its position in the structure, that this position is not available anymore for Mn 2+ ions in a soaking experiment and that the reduced flexibility in the crystal prevents Mn 2+ from entering both metal-binding sites.
The presence or absence of the bridging hydroxide was investigated by examining a difference electron density synthesis. This map clearly indicated the zpresence of the bridging hydroxide of the Mn 2 (OH À )-center all the six variants (1, 2, 3, 6, 7, and 8), in which the less tightly bound Mn500 is present. Five of these (1, 2, 3, 7, and 8) contain both Mn 2+ ions in positions corresponding to the ones observed in the wt-HsProl. The remaining one (variant 6) features an architecture, in which only one Mn 2+ (Mn500) is present in the active site, and in which Mn499 has been replaced by the amino group of Lys412. It is indeed a bit surprising to find some electron density for the hydroxide ion in this case, but it is clearly there, although significantly weaker than in the other five variants. The fact that the hydroxide ion is always present when Mn500 is also present seems to suggest that the role of the less tightly bound Mn500 is to bind the nucleophile and the role of the tightly bound Mn499 is to activate it.
Chain disorder and displacement of important active site residues
In the two variants 2 (Ser202Phe, PDB Id 5MBZ) and 7 (Gly448Arg, PDB Id 5MC4) (see Table 1 ) partial disorder of important amino acid chains could be observed. In both cases, a small amino acid is replaced by a large and bulky amino acid, which leads to disorder in chain segments near the mutation sites. In variant 2, this eventually leads to a displacement of the important active site residue Tyr241 and in variant 7 of His255. Interestingly, Besio and colleagues reported in vitro studies, in which 22% of prolidase activity could be rescued for the Gly448Arg mutant by inducing chaperone expression [7] . This certainly supports the notion that disorder or reduced stability of certain chain segments are responsible for the reduction of the enzyme activity, although it does not provide an explanation of how the newly introduced bulky Arg side chain can be accommodated in the structure.
Rigidification of the active site
Variant 1 (Arg184Gln, PDB Id 5MBY) of the eight variants (Table 1) appears to be unique in the sense that the substrate seems to be turned over. In the electron density synthesis cleaved or partially cleaved substrate is clearly discernible, which indicates that this mutant is capable of catalyzing the hydrolysis reaction. The low remaining activity compared to the wt enzyme may result from the fact that the product does not diffuse out of the active site. This observation is accompanied by the fact that the normalized ADPs of the active site amino acids are lower by roughly 10% than those of the wt structure. It may therefore be concluded that the replacement of Arg184 by Gln leads to a slight rigidification of the active site of the enzyme and consequently a lower off-rate of the products. It is interesting to note that the Arg184Gln variant was the variant, which could only be crystallized in the presence of Mn 2+ , which also sets it apart from the other seven variants. Competitive inhibition by Pro with an inhibition constant of K i = 0.31 AE 0.04 mM in the pH range 7-9 had been reported earlier by Mock and Green [15] for wt prolidase, which lends some support to our hypothesis.
Flexibilization of the active site
The two deletion variants 3 (DTyr231, PDB Id 5MB0) and 8 (DGlu452, PDB Id 5MC5) are both characterized by an increased active site flexibility, as evidenced by the normalized ADPs of the active site residues. At the same time all active site residues are present in their 'native' conformation. Even the two metal positions are occupied as in the wt structure with Mn499 being more strongly bound than Mn500. Interestingly, both variants retain about 5% of the wt activity, which suggests that the deletion of both Tyr231 and Glu452 leads to a slight destabilization of the overall structure. Not surprisingly, their T m -values obtained from a thermal shift analysis (Table 1) are among the lowest of the eight variants. Only one variant (variant 5, Gly278Asp) exhibits a lower T m -value than the two deletion variants.
In summary, we could identify four mechanisms, which all lead to a reduction of prolidase enzyme activity. We believe, that having high quality structures of these prolidase variants available now presents a significant step forward in understanding the molecular basis of prolidase deficiency and hopefully will aid in the development of novel therapies.
Materials and methods

Cloning, expression, and purification
The pET28a plasmid containing the wt sequence of HsProl fused to an N-terminal HisTag followed by a TEV recognition site was used as a template for site-directed mutagenesis. Mutation specific primers were designed and purchased from Eurofins Genomics GmbH (Ebersberg, Germany). Point mutations in the PEPD gene were introduced using QuikChange Ò Site-Directed Mutagenesis Kit (Agilent Technologies, Berlin, Germany) following the manufacturer's manual. In brief, the DpnI-treated PCR product was used to transform XL1-Blue supercompetent cells, which were grown on agar plates in the presence of kanamycin. Three colonies from each mutant were grown in liquid colonies, and plasmids were isolated and subjected to DNA sequencing (Eurofins Genomics GmbH). Escherichia coli BL21-Rosetta cells were transformed with the plasmids containing the verified DNA sequence. LB-broth supplemented with chloramphenicol (34 mgÁL À1 ) and kanamycin (50 mgÁL À1 ) was inoculated 2 : 100 with an overnight culture of BL21-Rosetta-pET28a cells carrying the desired mutated gene for HsProl. Upon reaching an OD 600 value of 0.6-0.75 the temperature was decreased from 37°C to 30°C and the culture was supplemented with 1 mM IPTG. Protein expression was carried out for 4-5 h. Cells were collected by centrifugation (12 min at 17 700 g) followed by resuspension in lysis buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 0.5 mM 2-ME, 0.5 mM EDTA), recentrifugation (to eliminate broth contamination), and frozen at À20°C. Cells were lyzed in lysis buffer in the presence of lysozyme by 20 min sonication using 10 s pulse/20 s pause cycles (Bandelin Sonoplus, Berlin, Germany). Lyzed cells were subjected to centrifugation (40 min at 53 000 g). The supernatant was loaded onto an equilibrated affinity column (5 mL HisTrap HP; GE Healthcare Europe GmbH, Freiburg, Germany), washed extensively with wash buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 50 mM imidazole, 1 mM DTT) and eluted with elution buffer (20 mM Tris-HCl pH 7.4; 150 mM NaCl, 290 mM imidazole, 1 mM DTT, 0.1 mM EDTA). Eluted protein was dialyzed against storage buffer (20 mM TrisHCl pH 7.4, 125 mM NaCl, 2 mM DTT, 0.1 mM EDTA) and subjected to overnight TEV cleavage during the second step of dialysis. The HisTag cleavage was verified by a reverse HisTrap column. HisTag-free protein was subjected to preparative grade size-exclusion chromatography (Superdex 16/200 pg; GE Healthcare) conducted isocraticly in storage buffer. Peaks of highest purity were pooled, concentrated to 30-100 mgÁmL À1 , aliquoted, flash-frozen in LN 2 , and stored at À80°C. During all purification procedures the protein was kept on ice or at 4°C.
Thermal shift analysis
Melting points (T m -values) for the different prolidase variants were obtained from a thermal shift assay (TSA) as described in Reinhard et al. [16] . In short, the protein solution was incubated with the dye Sypro Orange and the fluorescence signal was measured as a function of temperature between 4 and 95°C. The inflection point of the fluorescence signal increase was interpreted as the apparent T mvalue. Each experiment was carried out at least twice. The T m -values for all prolidase variants studied are listed in Table 1 .
Crystallization, crystal soaking, and flash cooling
All eight prolidase variants were expressed and purified in the same fashion as described above. Crystals of the seven variants except variant 1 (Arg184Gln, 
Data collection and processing
All diffraction images were collected at the macromolecular crystallography beam line BL14.1 of the HelmholtzZentrum Berlin [17, 18] . For data collection, the crystals were mounted on a mini kappa goniometer of the MD2-microdiffractometer and kept cold (100 K) in a gaseous N 2 stream during the entire data collection time. Both native and long-wavelength (in order to address the Mn-Kabsorption edge) data sets for the prolidase-Mn complexes were obtained from the same crystal. All long-wavelength data sets were collected at either the peak of the anomalous scattering factor (Df″) curve (wt HsProl and Arg184Gln) or at a slightly shorter wavelength on the high-energy remote side of the peak wavelength (all others). The diffraction data were processed using XDSAPP [19, 20] . In contrast to the short-wavelength data, the long-wavelength data were processed keeping the Friedel pairs separate. All relevant data collection and processing parameters are listed in Table 2 .
Ion identification using anomalous scattering
The presence of Mn 2+ ions was investigated by examining anomalous difference electron density maps obtained from the long-wavelength diffraction data sets with the help of the program ANODE [21] . Due to the fact that the different data sets were collected at slightly different positions of the Df″-curve, the values for the peak heights can only be compared within a given data set and not between different data sets.
Structure solution and refinement
The structures were solved using the program PHASER [22] using human wild-type prolidase (PDB-Id: 5M4G, [9] ) as a search model. Structures were initially refined with REFMAC5 [23] . PHENIX.REFINE [24] was then used at the final stages of refinement with hydrogens added in riding positions and automatically applied NCS and TLS restraints. Occupancies of ions and ligands were refined in the final refinement cycles. The diffraction data precision index (DPI) was calculated using the Online_DPI web server [25] . Refinement and validation statistics are given in Table 3 .
Structure analysis
The program ACHESYM [26] was used to find the best origin of the unit cell and to place the model. In order to assess the effect of the mutations on the HsProl structure, all mutant structures were compared with the wt-HsProl structure (PDB-Id 5M4J, [9] ). Structures were superimposed with COOT [27] using the SSM method [14] and PYMOL (The PyMOL Molecular Graphics System, Version 1.8 Schr€ odinger, LLC, New York City, NY, USA). Normalized ADPs were calculated by dividing individual ADP values by the average ADP of a given structure. The average was taken overall protein atoms.
Accession numbers
All refined coordinates and corresponding structure factor amplitudes have been deposited in the protein data bank [28] with accession numbers 5MBY, 5MBZ, 5MC0, 5MC1, 5MC2, 5MC3, 5MC4, 5MC5, and 6H2P, 6H2Q. The raw diffraction images for both high resolution and low energy (anomalous) data sets were deposited in the Integrated Resource for Reproducibility in Macromolecular Crystallography (IRRMC) [29] with the accession codes linked to the respective PDB entries.
